Catalent Pharma Solutions has acquired Pharmapak Technologies Pty Ltd., a leading pharmaceutical packaging business based in New South Wales, Australia. The acquisition provides regional packaging capabilities and complements Catalent's existing facility in Braeside, Victoria from which Catalent produces oral dose products including softgels, Vegicaps capsules, and OptiShell capsules, for supply throughout Asia Pacific. Financial details were not disclosed.

The company will continue to operate as Pharmapak Technologies Pty Ltd. and retain its approximately 100 employees including its leadership team at its existing facility in Dee Why, New South Wales. Pharmapak's capabilities include primary and secondary packaging of oral pharmaceutical dose forms including blisters, bottles and a wide range of tertiary packaging services.

Source: Catalent